养正消积胶囊联合化疗治疗转移性乳腺癌的临床疗效及安全性
Efficacy and safety of Yangzheng Xiaoji capsule combined with chemotherapy in treating metastatic breast cancer

DOI: 10.6040/j.issn.1671-7554.0.2015.1144

Keywords: 转移性乳腺癌,联合化疗,T淋巴细胞亚群,养正消积胶囊,
Yangzheng Xiaoji capsule,Metastatic breast cancer,Combined chemotherapy,T lymphocyte cell subsets

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]	Elisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline(version 1.1)[J]. Eur J Cancer, 2009, 45(2): 228-247.
[2]	Holoubková E, Skrivanová K, Nedvěd J, et al. Methods of assessing quality of life in women with breast cancer-overview and basic characteristics[J]. Klin Onkol, 2015, 28(5): 332-337.
[3]	Motyka M, Dziubak M, Patrycja J. The sense of coherence and the quality of life of patients treated for breast cancer[J]. Przegl Lek, 2014, 71(5): 270-273.
[4]	Jiang X. Harnessing the immune system for the treatment of breast cancer[J]. J Zhejiang Univ Sci B, 2014,15(1):1-15.
[5]	陆永奎, 谢伟敏, 周文献, 等. 重组人血管内皮抑制素联合全身化疗治疗转移性乳腺癌的临床疗效观察[J]. 重庆医学, 2013, 42(18): 2074-2079. LU Yongkui, XIE Weimin, ZHOU Wenxian, et al. Clinical observation of Rh-endostatin combined with chemotherapy for metastatic breast cancer[J]. Chongqing Medicine, 2013, 42(18): 2074-2079.
[6]	王志光, 向培, 范先基, 等. 穴位埋线在GT方案治疗转移性乳腺癌中的应用[J]. 广东医学, 2013, 34(6): 959-962.
[7]	章巧琪, 万冬桂. 转移性乳腺癌的中医治疗现状[J]. 北京中医药大学学报(中医临床版), 2011, 18(4): 43-45.
[8]	张莹, 贾英杰, 陈军, 等.养正消积胶囊联合昂丹司琼预防乳腺癌化疗所致恶心呕吐的疗效[J]. 中国老年学杂志, 2012, 32(24): 5524-5525.
[9]	沈镇宙, 邵志敏. 乳腺肿瘤学[M]. 上海: 上海科学技术出版社, 2005: 1.
[10]	Wan C, Tang X, Tu XM, et al. Psychometric properties of the simplified Chinese version of the EORTC QLQ-BR53 for measuring quality of life for breast cancer patients[J]. Breast Cancer Res Treat, 2007, 105(2): 187-193.
[11]	Lee WH, Liu HE, Chang JY, et al. MPT0B169, a new tubulin inhibitor, inhibits cell growth and induces G2/M arrest in nonresistant and paclitaxel-resistant cancer cells[J]. Pharmacology, 2013, 92(1-2): 90-98.
[12]	Leitner S, Sweeney K, Oberg D, et al. Oncolytic adenoviral mutants with E1B19K gene deletions enhance gemcitabine-induced apoptosis in pancreatic carcinoma cells and anti-tumor efficacy in vivo[J]. Clin Cancer Res, 2009, 15(5): 1730-1740.
[13]	Xu B, Zhang XQ, Chi HD, et al. Consistent efficacy and safety of gemcitabine-paclitaxel in patients with metastatic breast cancer: a retrospective comparison of East Asian and global studies[J]. Asia Pac J Clin Oncol, 2014, 10(4): 330-339.
[14]	Vici P, Giotta F, Di Lauro L, et al. A multicenter phaseⅡrandomized trial of docetaxel/ gemcitabine versus docetaxel/ capecitabine as first-line treatment for advanced breast cancer: a gruppo oncologico italia meridionale study[J]. Oncology, 2011, 81(3-4): 230-236.
[15]	张振华. 吉西他滨联合多西紫杉醇治疗复发转移性乳腺癌疗效分析[J]. 肿瘤基础与临床, 2013, 26(6): 488-489. ZHANG Zhenhua. Efficacy of gemcitabine plus docetaxel in the treatment of recurrent metastatic breast cancer[J]. Journal of Basicand Clinicai Oncology, 2013, 26(6): 488-489.
[16]	白海亚, 马秀芬. 新辅助化疗对局部进展期乳腺癌患者T淋巴细胞亚群及NK细胞免疫功能的影响[J]. 中国免疫学杂志, 2012, 9(28): 843-845. BAI Haiya, MA Xiufen. T lymphocyte subsets immunity and NK cells in patients with locally advanced breast cancer submitted to neoadjuvant chemotherapy[J]. Chinese Journal of Immunology, 2012, 9(28): 843-845.
[17]	张剑, 吴敏, 张自森, 等. 养正消积胶囊对原发性肝癌肝动脉化疗栓塞术后患者细胞免疫功能及血管形成的影响[J]. 中国实验方剂学杂志, 2014, 20(13): 189-192. ZHANG Jian, WU Min, ZHANG Zisen, et al. Influence of Yangzheng Xiaoji capsule cellular immune function and angiogenesis in treating primary liver cancer after arterial chemoembolization[J]. Chinese Journal of Experimental Traditional Medical Formulae, 2014, 20(13): 189-192.

Full-Text